EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative in vitro biological activity of trastuzumab-associated PLGA nanoparticle formulations in gastric cancer cell models

Floriana Porcaro, Gaetano Cardinale, Piercarmine Porcaro, Pasquale Vito, Serena Voccola

Frontiers in Drug Delivery · 19.11.2026 · 6

DOI: 10.3389/fddev.2026.1990262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Drug Delivery, online erschienen am 19.11.2026. Verfasst von Floriana Porcaro und 4 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Trastuzumab is an anti-HER2 monoclonal antibody used in HER2-positive gastric cancer. PLGA-based nanoparticle systems may modulate antibody presentation and availability within engineered delivery platforms.

Methods

The in vitro effects of free trastuzumab and trastuzumab-associated PLGA nanoparticles were evaluated in NCI-N87 and AGS gastric cancer cell models. Cell viability and cytotoxicity were assessed using MTT and lactate dehydrogenase (LDH) release assays, respectively. Trastuzumab was associated with PLGA nanoparticles in three configurations: internally associated (IN), surface-associated (OUT), and combined internal/surface-associated (IN + OUT). Peripheral blood mononuclear cells (PBMCs) were included as effector cells in LDH co-culture experiments.

Results

Empty PLGA nanoparticles did not significantly reduce NCI-N87 metabolic viability in the MTT assay, whereas LDH release was detectable under PBMC co-culture conditions. In NCI-N87 cells, trastuzumab-associated formulations induced greater in vitro effects than control conditions, with a formulation-associated pattern. The combined IN + OUT configuration showed the strongest activity, followed by OUT, whereas IN displayed comparatively lower activity. In contrast, AGS cells showed statistically detectable but biologically modest responses, with cell viability remaining consistently high and LDH release showing lower, less differentiated changes.

Conclusion

The investigated trastuzumab-associated PLGA nanoparticle formulations exhibited differential in vitro biological responses in gastric cancer cell models, with the combined internal/surface-associated formulation showing the most pronounced effects in NCI-N87 cells. However, the experimental design does not establish whether these differences are specifically attributable to antibody spatial presentation, HER2-dependent mechanisms, or immune-mediated cytotoxicity. These preliminary findings support further comparative and mechanistic investigations of antibody-associated PLGA nanocarriers.

Zitieren

APA

Porcaro, F., Cardinale, G., Porcaro, P., Vito, P., & Voccola, S. (2026). Comparative in vitro biological activity of trastuzumab-associated PLGA nanoparticle formulations in gastric cancer cell models. Frontiers in Drug Delivery, 6. https://doi.org/10.3389/fddev.2026.1990262

Vancouver

Porcaro F, Cardinale G, Porcaro P, Vito P, Voccola S. Comparative in vitro biological activity of trastuzumab-associated PLGA nanoparticle formulations in gastric cancer cell models. Frontiers in Drug Delivery. 2026;6. doi:10.3389/fddev.2026.1990262

BibTeX
@article{Porcaro2026,
  author = {Porcaro, Floriana and Cardinale, Gaetano and Porcaro, Piercarmine and Vito, Pasquale and Voccola, Serena},
  title = {Comparative in vitro biological activity of trastuzumab-associated PLGA nanoparticle formulations in gastric cancer cell models},
  journal = {Frontiers in Drug Delivery},
  year = {2026},
  volume = {6},
  doi = {10.3389/fddev.2026.1990262}
}
Kostenlos starten →